Novavax, Inc. - Common Stock (NVAX)

Novavax Inc is a biotechnology company focused on the development and commercialization of innovative vaccines to prevent infectious diseases

The company harnesses its proprietary nanoparticle technology and adjuvant platforms to create safe and effective immunizations. Novavax aims to address public health challenges by producing vaccines for various diseases, prominently including those caused by emerging viral pathogens. Through its research and clinical trials, Novavax is committed to enhancing global health outcomes and responding efficiently to viral outbreaks.